Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients

Cancer Research

Volumn 68, Issue 14, 2008, Pages 5869-5877

  Wang Johanning, Feng ^a,b   Radvanyi, Laszlo ^b   Rycaj, Kiera ^a   Plummer, Joshua B ^a   Yan, Peisha ^c   Sastry, K Jagannadha ^a,b   Piyathilake, Chandrika J ^d   Hunt, Kelly K ^b   Johanning, Gary L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN HERV K; UNCLASSIFIED DRUG; VIRUS PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOGENOUS VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; T LYMPHOCYTE; BIOLOGICAL MODEL; BREAST; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DENDRITIC CELL; ENDOGENOUS RETROVIRUS; GENE EXPRESSION REGULATION; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DENDRITIC CELLS; ENDOGENOUS RETROVIRUSES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULIN G; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MODELS, BIOLOGICAL; T-LYMPHOCYTES;

EID: 48649083286     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6838     Document Type: Article

References (29)

1. Fetsch PA, Marincola FM, Abati A. The new melanoma markers: MART-1 and Melan-A (the NIH experience). Am J Surg Pathol 1999;23:607-10.
2. Lopes L, Fletcher K, Ikeda Y, Collins M. Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy. Cancer Immunol Immunother 2006;55:1011-6.
3. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
4. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A 1996;93:5177-84.
5. Lower R, Tonjes RR, Korbmacher C, Kurth R, Lower J. Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol 1995;69:141-9.
6. Seifarth W, Skladny H, Krieg-Schneider F, Reichert A, Hehlmann R, Leib-Mosch C. Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences. J Virol 1995;69:6408-16.
7. Etkind PR, Lumb K, Du J, Racevskis J. Type 1 HERV-K genome is spliced into subgenomic transcripts in the human breast tumor cell line T47D. Virology 1997;234:304-8.
8. Wang-Johanning F, Frost AR, Johanning GL, et al. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clin Cancer Res 2001;7:1553-60.
9. Wang-Johanning F. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 2003;22:1528-35.
10. Schiavetti F, Thonnard J, Colau D, Boon T, Coulie PG. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res 2002;62:5510-6.
11. Wang-Johanning F, LiuJ , Rycaj K, et al. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer 2007;120:81-90.
12. Wang-Johanning F, Gillespie GY, Grim J, et al. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects. Cancer Res 1998;58:1893-900.
13. Dolbier CL, Cocke RR, Leiferman JA, et al. Differences in functional immune responses of high vs. low hardy healthy individuals. J Behav Med 2001;24:219-29.
14. Garrison KE, Jones RB, Meiklejohn DA, et al. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007;3:e165.
15. Gerloni M, Zanetti M. CD4 T cells in tumor immunity. Springer Semin Immunopathol 2005;27:37-48.
16. Tureci O, Sahin U, Pfreundschuh M. Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today 1997;3:342-9.
17. Hartmann TB, Bazhin AV, Schadendorf D, Eichmuller SB. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy. Int J Cancer 2005;114:88-93.
18. Jager D, Unkelbach M, Frei C, et al. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun 2002;2:5.
19. Radvanyi L, Singh-SandhuD, Gallichan S, et al. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc Natl Acad Sci U S A 2005;102:11005-10.
20. Kadish AS, Einstein MH. Vaccine strategies for human papillomavirus- associated cancers. Curr Opin Oncol 2005;17:456-61.
21. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
22. Comoli P, Pedrazzoli P, Maccario R, et al. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. J Clin Oncol 2005;23:8942-9.
23. Foster AE, Rooney CM. Improving T cell therapy for cancer. Expert Opin Biol Ther 2006;6:215-29.
24. Gottschalk S, Heslop HE, Rooney CM. Adoptive immunotherapy for EBV-associated malignancies. Leuk Lymphoma 2005;46:1-10.
25. Dohmen K, ShigematsuH, Irie K, Ishibashi H. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma. Hepatogastroenterology 2003;50:1872-7.
26. Komori K, Hasegawa A, Kurihara K, et al. Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells. J Virol 2006;80:7375-81.
27. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
28. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004;351:2832-8.
29. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med 2005;353:2101-4.